Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 20 Issue: 7, August 2020

Acute Myeloid Leukemia: Changing Treatment Paradigms and Novel Agents in Development free to download

Volume:20   Issue: 7
Pp: 471-472
Heiko Konig and Joshua F. Zeidner
DOI: 10.2174/156800962008200714125648
Published on: 14 July, 2020

Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia

Volume:20   Issue: 7
Pp: 473-489
Vaibhav Agrawal*, Olumide B. Gbolahan, Maximilian Stahl, Amer M. Zeidan, Mohammad Abu Zaid, Sherif S. Farag and Heiko Konig*
DOI: 10.2174/1568009620666200502011059
Published on: 01 May, 2020

Targeting IDH Mutations in AML: Wielding the Double-edged Sword of Differentiation

Volume:20   Issue: 7
Pp: 490-500
Justin S. Becker and Amir T. Fathi*
DOI: 10.2174/1568009620666200424145622
Published on: 24 April, 2020

Autophagy Driven Extracellular Vesicles in the Leukaemic Microenvironment

Volume:20   Issue: 7
Pp: 501-512
Rebecca H. Horton, Tom Wileman and Stuart A. Rushworth*
DOI: 10.2174/1568009620666200428111051
Published on: 28 April, 2020

FLT3 Inhibition in Acute Myeloid Leukaemia – Current Knowledge and Future Prospects

Volume:20   Issue: 7
Pp: 513-531
Francesca L. Hogan, Victoria Williams and Steven Knapper*
DOI: 10.2174/1570163817666200518075820
Published on: 17 May, 2020

The Evolving AML Genomic Landscape: Therapeutic Implications

Volume:20   Issue: 7
Pp: 532-544
Sachi Horibata*, George Alyateem, Christin B. DeStefano and Michael M. Gottesman*
DOI: 10.2174/1568009620666200424150321
Published on: 24 April, 2020

Immune Checkpoint Inhibitors in AML-A New Frontier

Volume:20   Issue: 7
Pp: 545-557
Rohit Thummalapalli, Hanna A. Knaus, Ivana Gojo and Joshua F. Zeidner*
DOI: 10.2174/1568009620666200421081455
Published on: 20 April, 2020